Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

CT45, an Unexpected Link Between Hodgkin Lymphoma and Reproductive Germ Cells

26.02.2010
Hodgkin lymphoma, a distinctive group of malignant lymphoma first described by Thomas Hodgkin in 1832, remains mysterious in many aspects today, more than 175 years since its initial description. Unlike most lymphomas, where the affected lymphoid organs are overtaken by sheets of tumor cells, the malignant cells in Hodgkin lymphoma often exist as individual giant cells in solitude, interspersed in between numerous benign small lymphocytes.

The origin of these neoplastic giant cells, called Reed-Sternberg cells, and how they have attracted their accompanying benign lymphocytes, have baffled scientists and hematologists for many decades. These malignant cells are now considered to be derived from B lymphocytes, and yet they do not express many molecules that are found in most B lymphocytes, and doubts remain about the true origin of these malignant cells.

In a paper published in the Proceedings of the National Academy of Sciences (PNAS) earlier this month, the laboratory of Dr. Lloyd J. Old of the Ludwig Institute for Cancer Research (LICR), together with Dr. Yao-Tseng Chen at Weill Cornell Medical College and their collaborators, made the finding that CT45, a cancer/testis (CT) antigen normally expressed in testicular germ cells in both prenatal and adult life, is expressed by the Reed-Sternberg cells in most of the classical Hodgkin lymphomas.

CT antigen was a term coined by Old and Chen in 1996 to describe an unusual group of germ cell antigens that they and others had discovered in their quest for tumor antigens for cancer immunotherapy. This group of antigens is normally silenced in all other normal cells in adult, and yet is aberrantly activated and expressed in a subset of various human cancers, often eliciting immune response in cancer patients.

Chen and Old discovered CT45 in 2005 and went on to show that CT45 is expressed in many cancers, notably in ovarian cancer and lung cancer. In contrast to the expression of CT45 in these epithelial cancers, they described in the current paper that CT45 expression in Hodgkin lymphoma is much more frequent, particularly when compared to other CT antigens, which are expressed in 0-25% in Hodgkin lymphoma. This high frequency of strong expression of CT45 in Hodgkin lymphoma indicates that CT45 could be a cancer vaccine target for Hodgkin lymphoma and related grey-zone lymphoma—lymphomas that bear the characteristics of both classic Hodgkin lymphoma as well as diffuse large B cell lymphoma, or non-Hodgkin lymphoma.

Even more intriguing, this finding points to a link between the malignant transformation in Hodgkin lymphoma and the process of germ cell development. These findings strengthen the theory that CT-coding genes that are active at the earliest stages of life, silenced in normal adult tissue, and then re-expressed in cancer, are major contributors to the abnormal growth and invasive properties of cancer.

Contact:
Brian M. Brewer
Director of Communications
Cancer Research Institute
+1(212) 688-7515, ext. 242
bbrewer@cancerresearch.org
Reference Publication: Chen YT et al. Expression of cancer testes antigen CT45 in classical Hodgkin lymphoma and other B-cell lymphomas. Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3093-8. Epub 2010 Jan 26.

About the Ludwig Institute for Cancer Research (LICR) New York Branch of Human Cancer Immunology at Memorial Sloan-Kettering Cancer Center (MSKCC). The New York Branch of Human Cancer Immunology at Memorial Sloan-Kettering Cancer Center is one of the ten research branches of the Ludwig Institute for Cancer Research, a global non-profit institute committed to improving the understanding and control of cancer through integrated laboratory and clinical discovery.

The New York Branch of Human Cancer Immunology’s main objective is the identification of suitable targets for antibody-based and vaccine-based immunotherapies of cancer. Over the years, the laboratory has defined a wide range of antibodies that target cell surface antigens on human cancer cells, as well as a range of intracellular antigens targeted by humoral and cellular immune responses. Based on detailed serological, biochemical, cellular, immunohistochemical and genetic characterization, a number of these antibodies and tumor antigens have been selected for early phase clinical trials. http://www.licr.org

Brian M. Brewer | Newswise Science News
Further information:
http://www.licr.org
http://www.cancerresearch.org

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

DGIST develops 20 times faster biosensor

24.04.2017 | Physics and Astronomy

Nanoimprinted hyperlens array: Paving the way for practical super-resolution imaging

24.04.2017 | Materials Sciences

Atomic-level motion may drive bacteria's ability to evade immune system defenses

24.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>